首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1570944

C反应蛋白检测市场、机会、成长动力、产业趋势分析与预测，2024-2032

C-reactive Protein Testing Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月09日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023年，全球C反应蛋白检测市场价值约为32亿美元，预计到2032年将达到约44亿美元，2024-2032年复合年增长率为3.9%。这种增长是由慢性疾病患病率上升以及对 CRP 检测的需求不断增加所推动的，CRP 检测对于诊断和管理这些疾病至关重要。类风湿性关节炎、心血管疾病和糖尿病等慢性疾病需要透过 CRP 检测进行持续监测和管理。这些慢性病的增加加剧了对 CRP 检测的早期发现和持续管理的依赖。世界卫生组织 (WHO) 2023 年报告称，慢性病占全球死亡人数的 71%，凸显了对有效诊断和监测工具的迫切需求。因此，慢性病的激增正在推动全球对 CRP 检测的需求。

整个C反应蛋白检测产业根据检测范围、产品、检测类型、应用和地区进行分类。

依产品细分，C反应蛋白检测市场包括仪器、试剂盒和试剂。 2023年，试剂盒和试剂领域引领市场，营收达20亿美元。试剂盒和试剂用途广泛，并与各种仪器和平台相容。这种适应性适合多种 CRP 检测，包括酵素连结免疫吸附检测、免疫比浊检测和化学发光免疫检测，增强了它们在多种临床环境中的吸引力。许多 CRP 测试套件优先考虑使用者友善性和快速结果。这些功能在及时决策至关重要的临床环境中至关重要，使得这些试剂盒比复杂、耗时的方法更具吸引力。

C反应蛋白检测市场的检测类型包括化学发光免疫分析（CLIA）、酵素连结免疫吸附分析（ELISA）、免疫比浊分析等。免疫比浊分析领域预计将在预测期内以 16 亿美元的收入引领市场。免疫比浊分析因其经济实惠而脱颖而出，特别是与 CLIA 和 ELISA 等价格较高的选择相比。这种成本优势吸引了广泛的医疗保健提供者，特别是小型诊所和预算有限的实验室。这些检测因其快速处理和效率而闻名。

2023 年，北美 C 反应蛋白检测市场规模达 12 亿美元，并预计在未来几年大幅成长。该地区正在努力解决慢性病高发生率的问题，特别是心血管疾病和糖尿病。这种上升推动了对 CRP 检测的需求，因为监测 CRP 水平对于评估这些情况下的发炎很常见。北美先进的医疗基础设施和广泛的诊断技术进一步推动了 CRP 检测市场的发展。该地区采用创新诊断工具并积极主动地进行早期疾病检测，扩大了 CRP 检测的使用。

产业生态系统分析
产业影响力
- 成长动力
  - 发炎性疾病等慢性疾病的盛行率不断增加
  - 用于诊断和管理慢性病的 CRP 检测需求激增
  - 技术进步
  - 对直接到家测试服务的需求不断增长
- 产业陷阱与挑战
  - 缺乏标准化
成长潜力分析
监管环境
技术景观
报销场景
波特的分析
PESTEL分析
未来市场趋势
差距分析

第 4 章：竞争格局

介绍
公司股份分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
仪器仪表
试剂盒和试剂

第 6 章：市场估计与预测：按分析类型，2021 - 2032 年

主要趋势
化学发光免疫分析 (CLIA)
酵素连结免疫吸附测定法 (ELISA)
免疫比浊法
其他检测类型

第 7 章：市场估计与预测：按检测范围，2021 - 2032 年

主要趋势
高敏感度 CRP (hs-CRP)
标准CRP

第 8 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
心血管疾病
传染病
慢性发炎性疾病
其他应用

第 9 章：市场估计与预测：依最终用途，2021 - 2032 年

主要趋势
医院和诊所
诊断实验室
其他最终用户

第 10 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 11 章：公司简介

Abbott
Agilent technologies
Aidian
Boditech Med, Inc.
Creative diagnostics
CTK Biotech
Danaher
DxGen Corp
F. Hoffmann-La Roche Ltd.
Getein Biotech, Inc.
Goldsite diagnostics
HORIBA, Ltd
Laboratory Corporation of American Holding
LumiraDX
Merck KGaA
Optibio co., Ltd
Randox Laboratories Ltd.
Siemens Healthineers AG

简介目录

Product Code: 10749

The Global C-reactive Protein Testing Market was valued at approximately USD 3.2 billion in 2023 and is projected to reach around USD 4.4 billion by 2032, reflecting a CAGR of 3.9% from 2024-2032. This growth is driven by the rising prevalence of chronic disorders and an increasing demand for CRP testing, crucial for diagnosing and managing these conditions. Chronic ailments like rheumatoid arthritis, cardiovascular diseases, and diabetes require consistent monitoring and management, facilitated by CRP testing. The uptick in these chronic conditions has intensified the reliance on CRP tests for early detection and ongoing management. The World Health Organization (WHO) reported in 2023 that chronic diseases accounted for 71% of global deaths, highlighting the urgent need for effective diagnostic and monitoring tools. Consequently, this surge in chronic diseases is propelling the global demand for CRP testing.

The overall C-reactive protein testing industry is classified based on the detection range, product, assay type, application, and region.

Segmented by product, the C-reactive protein testing market includes instruments, kits, and reagents. In 2023, the kits and reagents segment led the market, generating revenues of USD 2 billion. Kits and reagents are versatile and compatible with various instruments and platforms. This adaptability caters to diverse CRP assays, including enzyme-linked immunosorbent assay, immunoturbidimetric assay, and chemiluminescence immunoassay, enhancing their appeal across multiple clinical environments. Many CRP testing kits prioritize user-friendliness and rapid results. Such features are vital in clinical settings where timely decisions are paramount, making these kits more appealing than intricate, time-consuming methods.

Assay types in the C-reactive protein testing market include chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), immunoturbidimetric assay, and others. The immunoturbidimetric assay segment is projected to lead the market with anticipated revenues of USD 1.6 billion during the forecast period. Immunoturbidimetric assays stand out for their affordability, especially compared to pricier options like CLIA and ELISA. This cost advantage appeals to a broad spectrum of healthcare providers, notably smaller clinics and budget-constrained laboratories. These assays are celebrated for their swift processing and efficiency.

In 2023, North America accounted for USD 1.2 billion in the C-reactive protein testing market and is poised for significant growth in the coming years. The region grapples with a high prevalence of chronic diseases, notably cardiovascular ailments and diabetes. This uptick drives the demand for CRP testing, as monitoring CRP levels is common for assessing inflammation in these conditions. North America's advanced healthcare infrastructure and broad access to diagnostic technologies further fuel the CRP testing market. The region's embrace of innovative diagnostic tools and a proactive stance on early disease detection amplify CRP test usage.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic disorders such as inflammatory diseases
  - 3.2.1.2 Surge in demand for CRP testing for diagnosis and management of chronic diseases
  - 3.2.1.3 Advances in technology
  - 3.2.1.4 Growing demand for direct-to-home testing services
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Lack of standardization
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Reimbursement scenario
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Instruments
5.3 Kits and reagents

Chapter 6 Market Estimates and Forecast, By Assay Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Chemiluminescence immunoassay (CLIA)
6.3 Enzyme-linked immunosorbent assay (ELISA)
6.4 Immunoturbidimetric assay
6.5 Other assay types

Chapter 7 Market Estimates and Forecast, By Detection Range, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 High-sensitivity CRP (hs-CRP)
7.3 Standard CRP

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Cardiovascular diseases
8.3 Infectious diseases
8.4 Chronic inflammatory diseases
8.5 Other applications

Chapter 9 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Hospitals and clinics
9.3 Diagnostic laboratories
9.4 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Italy
- 10.3.5 Spain
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.5.4 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 Saudi Arabia
- 10.6.2 South Africa
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa